申请人:G.D. Searle & Co.
公开号:EP0218782A1
公开(公告)日:1987-04-22
This invention encompasses a pharmaceutical composition comprising a pharmaceutical carrier and an effective lipoxygenase inhibiting amount of a compound of the formula:
wherein: R₁ and R₂ are the same or different members of the group consisting of 1,1-dimethylethyl, halo, phenyl and substituted phenyl; Alk is straight or branched chain alkylene; R4 is hydrogen or alkyl; R₃ is hydrogen or alkyl; or a cycloalkyl group. The formulations of this invention are useful as anti-inflammatory and anti-allergy agents. This invention also encompasses keto alcohols, ketons and aldehydes, with formulas
wherein R₁ and R₂ are the same or different members of the group consisting of 1,1-dimethyethyl, halo, phenyl or substituted phenyl; Alk is alkylene; R₃ is hydrogen or alkyl; with the limitation that R₁ each must be the same and R₂
wherein R₁ and R₂ are the same or different members of the group consisting of 1,1-dimethylethyl, halo, phenyl and substituted phenyl, Alk is straight or branched chain alkylene; and R₃ is hydrogen, alkyl, alkoxycarbonylalkyl or cycloalkyl.
本发明包括一种药物组合物,其中包含药物载体和有效抑制量的式化合物脂氧合酶:
其中R₁和R₂是由1,1-二甲基乙基、卤代、苯基和取代苯基组成的组中相同或不同的成员;Alk是直链或支链亚烷基;R4是氢或烷基;R₃是氢或烷基;或环烷基。本发明的制剂可用作抗炎剂和抗过敏剂。本发明还包括酮醇、酮和醛,其分子式为
其中 R₁ 和 R₂ 是由 1,1-二甲基乙基、卤代、苯基或取代苯基组成的组中相同或不同的成员;Alk 是亚烷基;R₃ 是氢或烷基;但 R₁ 和 R₂ 必须相同。
其中 R₁ 和 R₂ 是由 1,1-二甲基乙基、卤代、苯基和取代苯基组成的组中的相同或不同成员,Alk 是直链或支链亚烷基;R₃ 是氢、烷基、烷氧羰基烷基或环烷基。